I think people are giving AF way too much credit for this dip. We've been in news quiet. The ALS ph2A results were questionable in nonresponder population. More information needs to be provided before that ambiguity can be resolved. Investors don't like such grey area in any research study, so they sold. With no news to buoy sp, we continue decline. Much of this is natural to this sector during newsquiet. Combine that with the questions many need answered r/t the study results and we have an expected decline that is unrelated to AF.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.